What is Selank?
Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a modified analog of the naturally occurring immunomodulatory peptide Tuftsin, with an added Pro-Gly-Pro sequence to prevent rapid enzymatic degradation in the bloodstream. It is designed to act as a stable anxiolytic and cognitive enhancer.
How does Selank work?
Selank exerts its effects by modulating the neurotransmitter gamma-aminobutyric acid (GABA), enhancing its inhibitory action in the brain without the sedative, muscle-relaxant, or addictive side effects of traditional benzodiazepines. It also increases the expression of Brain-Derived Neurotrophic Factor (BDNF), regulates serotonin and dopamine levels, and stabilizes enkephalins (natural pain-relievers) in the blood.
Primary Documented Uses
- Reducing acute and chronic anxiety and stress
- Improving focus, mental clarity, and memory retention
- Supporting emotional stability and mood regulation
- Modulating immune function under chronic stress
Research Summary
Russian clinical trials have demonstrated that Selank is highly effective in treating generalized anxiety disorder (GAD) and neurasthenia, with efficacy comparable to low-dose benzodiazpines but with superior tolerability and no withdrawal symptoms. It has also been shown to improve focus, memory, and learning capacity in research models by optimizing brain wave activity and reducing neuroinflammation.
Legal and Regulatory Status
Selank is approved and registered as a pharmaceutical drug in Russia for the treatment of anxiety and cognitive disorders. It is not approved by the FDA for human use in the United States, where it is legally classified and sold as a research chemical.
Frequently Asked Questions
What is Selank?
Selank is A synthetic heptapeptide with potent anxiolytic (anti-anxiety) and nootropic properties, developed by the Russian Academy of Sciences.
How does Selank work?
Selank exerts its effects by modulating the neurotransmitter gamma-aminobutyric acid (GABA), enhancing its inhibitory action in the brain without the sedative, muscle-relaxant, or addictive side effects of traditional benzodiazepines. It also increases the expression of Brain-Derived Neurotrophic Factor (BDNF), regulates serotonin and dopamine levels, and stabilizes enkephalins (natural pain-relievers) in the blood.
What does research say about Selank?
Russian clinical trials have demonstrated that Selank is highly effective in treating generalized anxiety disorder (GAD) and neurasthenia, with efficacy comparable to low-dose benzodiazpines but with superior tolerability and no withdrawal symptoms. It has also been shown to improve focus, memory, and learning capacity in research models by optimizing brain wave activity and reducing neuroinflammation.
Is Selank FDA-approved or legally available?
Selank is approved and registered as a pharmaceutical drug in Russia for the treatment of anxiety and cognitive disorders. It is not approved by the FDA for human use in the United States, where it is legally classified and sold as a research chemical.